Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Longhu, primarily operating as Shanghai Zhonghua Pharmaceutical Co., Ltd., is a historic Chinese pharmaceutical company best known for its iconic "Dragon-Tiger" brand of topical analgesics and traditional remedies. Founded in the early 20th century, the company specializes in the production of essential balms, cooling oils, and medicated patches used for pain relief, inflammation, and respiratory discomfort. Its flagship product, Longhu Essential Balm, is a staple in Chinese households and has a significant international presence in Southeast Asia and Africa. Beyond its traditional portfolio, the company manufactures a range of over-the-counter (OTC) medicines and health products. Longhu remains a key player in the Chinese consumer healthcare market, leveraging its long-standing brand heritage and manufacturing expertise.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Longhu.